Ghaneshree Moonsamy

Dr. Ghaneshree Moonsamy

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2021 in Processes
Verified
Journal Article
Open access
PDF file
PMPrisha Mandree
Prisha Mandree
WMWendy Masika
Wendy Masika
JNJustin Naicker
Justin Naicker
GMGhaneshree Moonsamy
Ghaneshree Moonsamy
SRSantosh Ramchuran
Santosh Ramchuran
RLRajesh Lalloo
Rajesh Lalloo
Polycyclic aromatic hydrocarbons (PAHs) are reportedly toxic, ubiquitous and organic compounds that can persist in the environment and are released largely due to the incomplete combustion of fossil fuel. There is a range of microorganisms that are capable of degrading low molecular weight PAHs, such as naphthalene; however, fewer were reported to degrade higher molecular weight PAHs. Bacillus spp. has shown to be effective in neutralizing polluted streams containing hydrocarbons. Following the growing regulatory requirement to meet the PAH specification upon disposal of contaminated soil, the following study aimed to identify potential Bacillus strains that could effectively remediate low and high molecular weight PAHs from the soil. Six potential hydrocarbon-degrading strains were formulated into two prototypes and tested for the ability to remove PAHs from industry-contaminated soil. Following the dosing of each respective soil system with prototypes 1 and 2, the samples were analyzed for PAH concentration over 11 weeks against an un-augmented control system. After 11 weeks, the control system indicated the presence of naphthalene (3.11 µg·kg−1), phenanthrene (24.47 µg·kg−1), fluoranthene (17.80 µg·kg−1) and pyrene (28.92 µg·kg−1), which illustrated the recalcitrant nature of aromatic hydrocarbons. The soil system dosed with prototype 2 was capable of completely degrading (100%) naphthalene, phenanthrene and pyrene over the experimental period. However, the accumulation of PAHs, namely phenanthrene, fluoranthene and pyrene, were observed using prototype 1. The results showed that prototype 2, consisting of a combination of Bacillus cereus and Bacillus subtilis strains, was more effective in the biodegradation of PAHs and intermediate products. Furthermore, the bio-augmented system dosed with prototype 2 showed an improvement in the overall degradation (10–50%) of PAHs, naphthalene, phenanthrene and pyrene, over the un-augmented control system. The following study demonstrates the potential of using Bacillus spp. in a bioremediation solution for sites contaminated with PAHs and informs the use of biological additives for large-scale environmental remediation.

4 November 2024 in Microorganisms
Verified
Journal Article
Open access
PDF file
GMGhaneshree Moonsamy
Ghaneshree Moonsamy
YRYrielle Roets-Dlamini
Yrielle Roets-Dlamini
CLCebeni Nkosihawukile Langa
Cebeni Nkosihawukile Langa
SRSantosh Ramchuran
Santosh Ramchuran
The use of probiotics has been gaining popularity in terms of inclusion into human diets over recent years. Based on properties exerted by these organisms, several benefits have been elucidated and conferred to the host. Bacteria have been more commonly used in probiotic preparations compared to yeast candidates; however, yeast exhibit several beneficial properties, such as the prevention and treatment of diarrhea, the production of antimicrobial agents, the prevention of pathogen adherence to intestinal sites, the maintenance of microbial balance, the modulation of the immune system, antibiotic resistance, amongst others. Saccharomyces boulardii is by far the most studied strain; however, the potential for the use of other yeast candidates, such as Kluyveromyces lactis and Debaryomyces hansenii, amongst others, have also been evaluated in this review. Furthermore, a special focus has been made regarding the production considerations for yeast-based probiotics and their formulation into different delivery formats. When drafting this review, evidence suggests that the use of yeasts, both wild-type and genetically modified candidates, can extend beyond gut health to support skin, the respiratory system, and overall immune health. Hence, this review explores the potential of yeast probiotics as a safe, effective strategy for preventative health in humans, highlighting their mechanisms of action, clinical applications, and production considerations.

9 December 2020 in Bioremediation Journal
Verified
Journal Article
Closed access
WMWendy Snoyolo Masika
Wendy Snoyolo Masika
GMGhaneshree Moonsamy
Ghaneshree Moonsamy
PMPrisha Mandree
Prisha Mandree
SRSantosh Ramchuran
Santosh Ramchuran
RLRajesh Lalloo
Rajesh Lalloo
TKTukayi Kudanga
Tukayi Kudanga
Petroleum hydrocarbons are toxic to all forms of life; therefore, environmental pollution caused by petroleum is of great concern. Bio-based environmentally friendly strategies are preferred for the remediation of these contaminated sites. This study investigated the potential of consortia of Bacillus spp for the removal of petroleum hydrocarbons from synthetic media and industrial effluents. Of the 115 isolates, the top three performing isolates, designated as GPA 11.2, GPA 7.1, GPA 3.5, were selected and identified using 16 s rDNA as Bacillus subtilis (GPA 11.2), Bacillus methylotrophicus (GPA 3.5), and Bacillus amyloliquefaciens (GPA 7.1). The three strains were combined to produce three different consortia designated as prototype 1, prototype 2, and prototype 3. The bioremediation potential of each consortium was evaluated by Gas Chromatography (GC) using industrial effluents that contained hydrocarbons. Results indicated that the bulk of the contaminants were removed during the first 48 h; and removal (%) did not increase significantly after 72 h. The total petroleum hydrocarbons (TPH) (C8–C28) removal rates from synthetic effluent after 48 h of treatment using prototype 1, prototype 2, and prototype 3 were 64.9%, 30.0%, and 79.8%, respectively. The TPH (C8–C28) removal rate from true effluents after 48 h of treatment using prototype 1, prototype 2, and prototype 3 consortia were 64.5%, 53.6%, and 52.7%, respectively. The results showed that the best performing consortium was prototype 1. This study has demonstrated the potential application of Bacillus consortia as bioremediation agents for the treatment of hydrocarbon-contaminated sites.

1 April 2025 in Fermentation
Verified
Journal Article
Open access
PDF file
GMGhaneshree Moonsamy
Ghaneshree Moonsamy
SSSarisha Singh
Sarisha Singh
YRYrielle Roets-Dlamini
Yrielle Roets-Dlamini
KBKoketso Kenneth Baikgaki
Koketso Kenneth Baikgaki
SRSantosh Ramchuran
Santosh Ramchuran
Saccharomyces cerevisiae var. boulardii is a probiotic yeast widely recognized for its ability to enhance gut health and modulate a host’s microbiome. However, there are limited data on its large-scale cultivation in stirred tank bioreactors and subsequent downstream processing into a functional probiotic product. Different recipe formulations were evaluated and the recipe with the highest biomass yield and lowest process time was selected. Once the optimised batch was validated in the replicate batches, the statistical analysis indicated a high level of reproducibility, with low variability across key performance indicators such as biomass concentration (unit), CFU production (CFU.mL−1), and substrate utilization efficiency (g.g−1). The mean growth age in the bioreactor was 25.33 ± 1.16 h, with a CV of 4.56%, indicating minimal deviation between batches. Similarly, the final viable concentration exhibited a mean of 1.46 × 108 CFU.mL−1 with a CV of 11.68%, remaining within an acceptable range for biological processes, while the final biomass concentration had the lowest variability (CV of 3.94%) and a 95% CI of 12.134–13.266 g.L−1, highlighting the accuracy and consistency of the process. Productivity indicators, including cell productivity (growth time—biomass) and YPP (biomass), maintained low CV values (3.933% and 3.389%, respectively), reinforcing process efficiency and stability. The overlapping 95% confidence intervals across batches further confirmed that no statistically significant deviations existed, ensuring minimal batch-to-batch variability, and validating the scalability and robustness of the fermentation process. These findings provide strong evidence for the feasibility of large-scale probiotic yeast production that meets industrial production standards. The final freeze-dried product retained an 81% viability post-exposure to simulated gastrointestinal conditions, meeting WHO probiotic viability standards. These findings establish a scalable, optimized process for probiotic yeast production, with potential applications in biopharmaceutical manufacturing and functional food development, as confirmed by the techno-economic evaluations performed using SuperPro Designer®.

1 June 2023 in Heliyon
Verified
Journal Article
Open access
VCVarsha Chhiba
Varsha Chhiba
PPPriyen Pillay
Priyen Pillay
SMSibongile Mtimka
Sibongile Mtimka
GMGhaneshree Moonsamy
Ghaneshree Moonsamy
LKLusisizwe Kwezi
Lusisizwe Kwezi
TTTsepo Lebiletsa Tsekoa
Tsepo Lebiletsa Tsekoa
The unique metagenomic, metaviromic libraries and indigenous micro diversity within Southern Africa have the potential for global beneficiation in academia and industry. Microorganisms that flourish at high temperatures, adverse pH conditions, and high salinity are likely to have enzyme systems that function efficiently under those conditions. These attributes afford researchers and industries alternative approaches that could replace existing chemical processes. Thus, a better understanding of African microbial/genetic diversity is crucial for the development of “greener” industries. A concerted drive to exploit the potential locked in biological resources has been previously seen with companies such as Diversa Incorporated and Verenium (Badische Anilin-und SodaFabrik-BASF) both building business models that pioneered the production of high-performance specialty enzymes for a variety of different industrial applications. The market potential and accompanying industry offerings have not been fully exploited in South Africa, nor in Africa at large. Utilization of the continent's indigenous microbial repositories could create long-lasting, sustainable growth in various production sectors, providing economic growth in resource-poor regions. By bolstering local manufacture of high-value bio-based products, scientific and engineering discoveries have the potential to generate new industries which in turn would provide employment avenues for many skilled and unskilled laborers. The positive implications of this could play a role in altering the face of business markets on the continent from costly import-driven markets to income-generating export markets. This review focuses on identifying microbially diverse areas located in South Africa while providing a profile for all associated microbial/genetically derived libraries in this country. A comprehensive list of all the relevant researchers and potential key players is presented, mapping out existing research networks for the facilitation of collaboration. The overall aim of this review is to facilitate a coordinated journey of exploration, one which will hopefully realize the value that South Africa's microbial diversity has to offer.

1 October 2024 in Preprints.org
Verified
Preprint
Open access
PDF file
GMGhaneshree Moonsamy
Ghaneshree Moonsamy
YRYrielle Roets-Dlamini
Yrielle Roets-Dlamini
CLCebeni Nkosihawukile Langa
Cebeni Nkosihawukile Langa
SRSantosh Ramchuran
Santosh Ramchuran
The use of probiotics has been gaining popularity in terms of inclusion into human diets over recent years. Based on properties exerted by these living organisms, several benefits have been elucidated and conferred to the host. Bacteria has been more commonly used in probiotic preparations, in comparison to yeast candidates, however, yeast exhibit several beneficial properties such as the prevention and treatment of diarrhoea, production of antimicrobial agents, prevention of pathogen adherence to intestinal sites, maintain microbial balance, modulation of the immune system, resistant to some antibiotics, amongst others. This review details the use of yeast organisms as biotherapeutics and has a special focus on production considerations and their formulation into different delivery formats.